Globe Life (NYSE:GL) Director Cheryl Alston Sells 8,258 Shares of Stock

Globe Life Inc. (NYSE:GL) Director Cheryl Alston sold 8,258 shares of the stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the completion of the transaction, the director owned 16,621 shares of the company’s stock, valued at $2,979,148.04. This trade represents a 33.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Globe Life Trading Up 1.6%

Shares of GL opened at $179.28 on Friday. The business’s 50-day moving average price is $158.33 and its 200 day moving average price is $147.32. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $13.92 billion, a P/E ratio of 12.40 and a beta of 0.49. Globe Life Inc. has a 1-year low of $116.73 and a 1-year high of $181.15.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The firm had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the company posted $3.07 earnings per share. Globe Life’s quarterly revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Analysts expect that Globe Life Inc. will post 15.64 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. The ex-dividend date is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. Globe Life’s payout ratio is currently 9.13%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. Truist Financial lifted their price objective on shares of Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Friday, April 24th. Keefe, Bruyette & Woods reissued a “moderate buy” rating and set a $168.00 target price on shares of Globe Life in a research note on Thursday, March 26th. Piper Sandler increased their target price on Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a report on Tuesday, May 26th. Finally, Morgan Stanley raised their target price on Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, May 21st. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $175.89.

Institutional Trading of Globe Life

A number of hedge funds have recently made changes to their positions in the stock. CYBER HORNET ETFs LLC acquired a new stake in shares of Globe Life during the second quarter worth approximately $28,000. Hilton Head Capital Partners LLC acquired a new position in Globe Life in the 4th quarter valued at approximately $30,000. MUFG Securities EMEA plc purchased a new stake in Globe Life in the 2nd quarter worth approximately $31,000. Torren Management LLC purchased a new stake in Globe Life in the 4th quarter worth approximately $37,000. Finally, AdvisorNet Financial Inc boosted its stake in shares of Globe Life by 41.1% during the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after buying an additional 92 shares during the period. 81.61% of the stock is owned by hedge funds and other institutional investors.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.